Back to Search
Start Over
Effects of the Dipeptidyl Peptidase 4 Inhibitor Alogliptin on Blood Pressure in Hypertensive Patients with Type 2 Diabetes Mellitus.
- Source :
- American Journal of Hypertension; Jul2019, Vol. 32 Issue 7, p695-702, 8p
- Publication Year :
- 2019
-
Abstract
- The article offers a study on the effects of alogliptin on blood pressure and arterial stiffness in hypertensive patients with type 2 diabetes mellitus (T2DM). Topics discussed include Blood pressure and brachial-ankle pulse wave velocity (baPWV) were measured before and after 3, 6, and 12 months of treatment with alogliptin in 22 hypertensive patients with T2DM; and concludes that alogliptin was associated with improvements not only in glucose metabolism.
Details
- Language :
- English
- ISSN :
- 08957061
- Volume :
- 32
- Issue :
- 7
- Database :
- Complementary Index
- Journal :
- American Journal of Hypertension
- Publication Type :
- Academic Journal
- Accession number :
- 136918187
- Full Text :
- https://doi.org/10.1093/ajh/hpz065